Skip to Main Content Skip to Site Map Skip to Accessibility Statement
Home Formulary 3.0 Respiratory System 3.1 Bronchodilators 3.1.4 Compound bronchodilator preparations

3.1.4 Compound bronchodilator preparations

LABA/LAMA combination inhalers [COPD only]

ChoiceDrugCarbon FootprintDose Counter Present (D)

Formulary Choices

Aclidinium/formoterol

Duaklir Genuair®▼ DPI 340/12

D
Indacaterol/glycopyrronium

Ultibro Breezhaler® DPI 85/43 inhalation powder capsules with device

capsules with device
Tiotropium/olodaterol

Spiolto Respimat® soft mist 2.5/2.5 inhalation solution

D
Umeclidinium/vilanterol

Anoro Ellipta ®▼ DPI 55/22

D

If MDI required:

Glycopyrronium/Formoterol
Bevespi Aerosphere 7.2/5 micrograms pressurised inhalation

Symbol Carbon indicator

Low Carbon Footprint (<2kg CO2e per inhaler)

High Carbon Footprint (6-20kg CO2e per inhaler)

Highest Carbon Footprint (>34kg CO2e per inhaler)

Prescribing Notes

  • All LABA/LAMA combination inhalers are less costly than the combined costs of the single inhalers and may be more convenient for patients.

Cautions

Refer to 3.1.2

Also in this Section